Inventor
KRAMER JAMES BERNARD
US22 patents
⚠️ This page may combine multiple inventors who share the name “KRAMER JAMES BERNARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CAYMAN CHEMICAL CO INC
12 patentsUS9487478B2Nov 8, 2016
Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
CAYMAN CHEMICAL CO INC4 citations82
US9180116B2Nov 10, 2015
Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
CAYMAN CHEMICAL CO INC6 citations82
US9440919B2Sep 13, 2016
Difluorolactam compositions for EP4-mediated osteo related diseases and conditions
CAYMAN CHEMICAL CO INC4 citations81
US9701630B2Jul 11, 2017
Difluorolactam compositions for EP4-mediated osteo related diseases and conditions
CAYMAN CHEMICAL CO INC2 citations70
US11884624B2Jan 30, 2024
Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
CAYMAN CHEMICAL CO INC0 citations61
US11345690B2May 31, 2022
Methods of synthesizing a difluorolactam analog
CAYMAN CHEMICAL CO INC0 citations61
US11066361B2Jul 20, 2021
Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
CAYMAN CHEMICAL CO INC0 citations61
US9914725B2Mar 13, 2018
Methods of synthesizing a difluorolactam analog
CAYMAN CHEMICAL CO INC0 citations51
US10556862B2Feb 11, 2020
Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
CAYMAN CHEMICAL CO INC0 citations49
US9126973B2Sep 8, 2015
Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases
CAYMAN CHEMICAL CO INC0 citations46
US10729810B2Aug 4, 2020
Methods, systems, and compositions for promoting bone growth
CAYMAN CHEMICAL CO INC0 citations39
US9688627B2Jun 27, 2017
Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
CAYMAN CHEMICAL CO INC0 citations38
WARNER LAMBERT CO
6 patentsUS5990146ANov 23, 1999
Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
WARNER LAMBERT CO92 citations96
US6218388B1Apr 17, 2001
Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
WARNER LAMBERT CO37 citations91
US7022711B2Apr 4, 2006
2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones
WARNER LAMBERT CO12 citations83
US7169778B2Jan 30, 2007
Pteridinones as kinase inhibitors
WARNER LAMBERT CO15 citations82
US7501425B1Mar 10, 2009
Bicyclic pyrimidines and bicyclic 3,4-dihydropyprimidines as inhibitors of cellular proliferation
WARNER LAMBERT CO15 citations81
US6683183B2Jan 27, 2004
Pyridotriazines and pyridopyridazines
WARNER LAMBERT CO2 citations62